Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study

Journal:

Nature Communications

Published:

2025-11-26

DOI:

10.1038/s41467-025-66590-2

Affiliations:

8

Authors:

22

Go to article

Institutions	Authors	Share
Institute Jules Bordet, ULB, Belgium	15.000000 15.000000	0.68
Rejuversen Senescence Therapeutics, Spain	2.000000	0.09
University Hospital Saint-Luc, Belgium	1.000000	0.05
CHU Brugmann, Belgium	1.000000	0.05
CHU UCL Namur, Belgium	1.000000	0.05
University Hospitals Leuven (UZ Leuven), Belgium	1.000000	0.05
Ziekenhuis aan de Stroom (ZAS), Belgium	0.500000	0.02
Peter MacCallum Cancer Centre (Peter Mac), Australia	0.500000	0.02

Interested in Oncology and Carcinogenesis?